194 related articles for article (PubMed ID: 33339145)
1. α-Conotoxin TxID and [S9K]TxID, α3β4 nAChR Antagonists, Attenuate Expression and Reinstatement of Nicotine-Induced Conditioned Place Preference in Mice.
Li X; You S; Xiong J; Qiao Y; Yu J; Zhangsun D; Luo S
Mar Drugs; 2020 Dec; 18(12):. PubMed ID: 33339145
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a novel α-conotoxin TxID from Conus textile that potently blocks rat α3β4 nicotinic acetylcholine receptors.
Luo S; Zhangsun D; Zhu X; Wu Y; Hu Y; Christensen S; Harvey PJ; Akcan M; Craik DJ; McIntosh JM
J Med Chem; 2013 Dec; 56(23):9655-63. PubMed ID: 24200193
[TBL] [Abstract][Full Text] [Related]
3. Single Amino Acid Substitution in α-Conotoxin TxID Reveals a Specific α3β4 Nicotinic Acetylcholine Receptor Antagonist.
Yu J; Zhu X; Harvey PJ; Kaas Q; Zhangsun D; Craik DJ; Luo S
J Med Chem; 2018 Oct; 61(20):9256-9265. PubMed ID: 30252466
[TBL] [Abstract][Full Text] [Related]
4. The α3β4* nicotinic acetylcholine receptor subtype mediates nicotine reward and physical nicotine withdrawal signs independently of the α5 subunit in the mouse.
Jackson KJ; Sanjakdar SS; Muldoon PP; McIntosh JM; Damaj MI
Neuropharmacology; 2013 Jul; 70():228-35. PubMed ID: 23416040
[TBL] [Abstract][Full Text] [Related]
5. Fluorescently Labeled α-Conotoxin TxID, a New Probe for α3β4 Neuronal Nicotinic Acetylcholine Receptors.
Huang M; Zhu X; Yang Y; Tan Y; Luo S; Zhangsun D
Mar Drugs; 2022 Aug; 20(8):. PubMed ID: 36005514
[TBL] [Abstract][Full Text] [Related]
6. α-Conotoxin [S9A]TxID Potently Discriminates between α3β4 and α6/α3β4 Nicotinic Acetylcholine Receptors.
Wu Y; Zhangsun D; Zhu X; Kaas Q; Zhangsun M; Harvey PJ; Craik DJ; McIntosh JM; Luo S
J Med Chem; 2017 Jul; 60(13):5826-5833. PubMed ID: 28603989
[TBL] [Abstract][Full Text] [Related]
7. The role of alpha6-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal.
Jackson KJ; McIntosh JM; Brunzell DH; Sanjakdar SS; Damaj MI
J Pharmacol Exp Ther; 2009 Nov; 331(2):547-54. PubMed ID: 19644040
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of disulfide-rich cyclic α-conotoxin [S9A]TxID analogues as novel α3β4 nAChR antagonists.
Wang S; Ren J; Li R; Li X; Zhangsun D; Wu Y; Luo S
Bioorg Chem; 2021 Jul; 112():104875. PubMed ID: 33823404
[TBL] [Abstract][Full Text] [Related]
9. Effect of Methionine Oxidation and Substitution of α-Conotoxin TxID on α3β4 Nicotinic Acetylcholine Receptor.
Ren J; Li R; Ning J; Zhu X; Zhangsun D; Wu Y; Luo S
Mar Drugs; 2018 Jun; 16(6):. PubMed ID: 29925760
[TBL] [Abstract][Full Text] [Related]
10. α-Conotoxin TxIB: A Uniquely Selective Ligand for α6/α3β2β3 Nicotinic Acetylcholine Receptor Attenuates Nicotine-Induced Conditioned Place Preference in Mice.
You S; Li X; Xiong J; Zhu X; Zhangsun D; Zhu X; Luo S
Mar Drugs; 2019 Aug; 17(9):. PubMed ID: 31443523
[No Abstract] [Full Text] [Related]
11. Loop2 Size Modification Reveals Significant Impacts on the Potency of α-Conotoxin TxID.
Dong J; Zhang P; Xie J; Xie T; Zhu X; Zhangsun D; Yu J; Luo S
Mar Drugs; 2023 May; 21(5):. PubMed ID: 37233480
[TBL] [Abstract][Full Text] [Related]
12. The α3β4 nAChR partial agonist AT-1001 attenuates stress-induced reinstatement of nicotine seeking in a rat model of relapse and induces minimal withdrawal in dependent rats.
Yuan M; Malagon AM; Yasuda D; Belluzzi JD; Leslie FM; Zaveri NT
Behav Brain Res; 2017 Aug; 333():251-257. PubMed ID: 28693859
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a potent and selective α3β4 nicotinic acetylcholine receptor antagonist from an α-conotoxin synthetic combinatorial library.
Chang YP; Banerjee J; Dowell C; Wu J; Gyanda R; Houghten RA; Toll L; McIntosh JM; Armishaw CJ
J Med Chem; 2014 Apr; 57(8):3511-21. PubMed ID: 24649848
[TBL] [Abstract][Full Text] [Related]
14. High affinity α3β4 nicotinic acetylcholine receptor ligands AT-1001 and AT-1012 attenuate cocaine-induced conditioned place preference and behavioral sensitization in mice.
Khroyan TV; Yasuda D; Toll L; Polgar WE; Zaveri NT
Biochem Pharmacol; 2015 Oct; 97(4):531-541. PubMed ID: 26256075
[TBL] [Abstract][Full Text] [Related]
15. Alanine scan of α-conotoxin RegIIA reveals a selective α3β4 nicotinic acetylcholine receptor antagonist.
Kompella SN; Hung A; Clark RJ; Marí F; Adams DJ
J Biol Chem; 2015 Jan; 290(2):1039-48. PubMed ID: 25411242
[TBL] [Abstract][Full Text] [Related]
16. AT-1001: a high affinity and selective α3β4 nicotinic acetylcholine receptor antagonist blocks nicotine self-administration in rats.
Toll L; Zaveri NT; Polgar WE; Jiang F; Khroyan TV; Zhou W; Xie XS; Stauber GB; Costello MR; Leslie FM
Neuropsychopharmacology; 2012 May; 37(6):1367-76. PubMed ID: 22278092
[TBL] [Abstract][Full Text] [Related]
17. AT-1001: a high-affinity α3β4 nAChR ligand with novel nicotine-suppressive pharmacology.
Cippitelli A; Wu J; Gaiolini KA; Mercatelli D; Schoch J; Gorman M; Ramirez A; Ciccocioppo R; Khroyan TV; Yasuda D; Zaveri NT; Pascual C; Xie XS; Toll L
Br J Pharmacol; 2015 Apr; 172(7):1834-45. PubMed ID: 25440006
[TBL] [Abstract][Full Text] [Related]
18. Differential roles of α6β2* and α4β2* neuronal nicotinic receptors in nicotine- and cocaine-conditioned reward in mice.
Sanjakdar SS; Maldoon PP; Marks MJ; Brunzell DH; Maskos U; McIntosh JM; Bowers MS; Damaj MI
Neuropsychopharmacology; 2015 Jan; 40(2):350-60. PubMed ID: 25035086
[TBL] [Abstract][Full Text] [Related]
19. α-Conotoxin VnIB from Conus ventricosus is a potent and selective antagonist of α6β4* nicotinic acetylcholine receptors.
van Hout M; Valdes A; Christensen SB; Tran PT; Watkins M; Gajewiak J; Jensen AA; Olivera BM; McIntosh JM
Neuropharmacology; 2019 Oct; 157():107691. PubMed ID: 31255696
[TBL] [Abstract][Full Text] [Related]
20. A Novel α4/7-Conotoxin QuIA Selectively Inhibits α3β2 and α6/α3β4 Nicotinic Acetylcholine Receptor Subtypes with High Efficacy.
Wang L; Wu X; Zhu X; Zhangsun D; Wu Y; Luo S
Mar Drugs; 2022 Feb; 20(2):. PubMed ID: 35200675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
